Tag: generic drug approval

FDA's 180-Day Exclusivity: Benefits for First Generic Applicants

Explore how FDA's 180-day exclusivity rewards first generic applicants, the risks of forfeiture, and proposed reforms like the CGT model to improve patient access.

Complex Generic Formulations: The Hidden Challenges in Proving Bioequivalence

Exploring the scientific and regulatory hurdles of complex generic formulations, including bioequivalence challenges, reverse engineering, and future solutions for patient access.

How the FDA Ensures Generic Drug Safety Through Manufacturing Oversight

The FDA ensures generic drug safety through strict manufacturing oversight, bioequivalence testing, global inspections, and continuous monitoring. Learn how generics meet the same standards as brand-name drugs.